Skip to main content

Cancer drug listing

Find detailed information for nearly 200 cancer drugs, including brand and generic names for each drug, what it is intended to treat, how it is administered, and possible side effects.

To find out if a Food and Drug Administration-approved drug is in short supply, visit the FDA website.

Showing results for:

Corticosteroids

Drug name(s)

Decadron ®

Approved for

  • Other Blood Cancers

Cytarabine

Drug name(s)

Cytosar-U® Cytosine arabinoside Ara-C Cytarabine Liposomal cytarabine DepoCyt®

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)
  • Acute Myeloid Leukemia (AML)
  • Chronic Myeloid Leukemia (CML)
  • Lymphoma

Dacarbazine

Drug name(s)

DTIC-Dome® Dacarbazine

Approved for

  • Lymphoma
  • Hodgkin Lymphoma (HL)

Daratumumab

Drug name(s)

Darzalex® Daratumumab

Approved for

  • Myeloma

Daratumumab and hyaluronidase-fihj

Drug name(s)

Darzalex Faspro® Daratumumab and hyaluronidase-fihj

Approved for

  • Myeloma
  • Myeloma-related Amyloidosis

Darbepoetin alfa

Drug name(s)

Aranesp® Darbepoetin alfa

Approved for

  • Other Blood Cancers

Dasatinib

Drug name(s)

Sprycel® Phyrago® Dasatinib

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)
  • Chronic Myeloid Leukemia (CML)

Daunorubicin

Drug name(s)

Cerubidine® Daunorubicin

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)

Daunorubicin and cytarabine

Drug name(s)

Vyxeos® Daunorubicin and cytarabine

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)

Decitabine

Drug name(s)

Dacogen® Decitabine

Approved for

  • Leukemia
  • Chronic Myelomonocytic Leukemia (CMML)
  • Myelodysplastic Syndromes (MDS)

Decitabine and cedazuridine

Drug name(s)

Inqovi® Decitabine and cedazuridine

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)
  • Chronic Myelomonocytic Leukemia (CMML)
  • Myelodysplastic Syndromes (MDS)

Deferasirox

Drug name(s)

Exjade® Jadenu® Deferasirox

Approved for

  • Other Blood Cancers

Deferoxamine mesylate

Drug name(s)

Desferal® DFO Deferoxamine mesylate

Approved for

  • Other Blood Cancers

Defibrotide sodium

Drug name(s)

Defitelio® Defibrotide sodium

Approved for

  • Other Blood Cancers

Denileukin diftitox-cxdl

Drug name(s)

Denileukin diftitox-cxdl Lymphir™

Approved for

  • Non-Hodgkin Lymphoma (NHL)

Denosumab

Drug name(s)

Xgeva® Denosumab

Approved for

  • Myeloma

Dexamethasone

Drug name(s)

Prednisone Decadron® Medrol® Methylprednisolone Dexamethasone

Approved for

  • Other Blood Cancers

Doxorubicin

Drug name(s)

Adriamycin® Doxorubicin

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)
  • Acute Myeloid Leukemia (AML)
  • Lymphoma
  • Hodgkin Lymphoma (HL)
  • Non-Hodgkin Lymphoma (NHL)

Glasdegib

Drug name(s)

Daurismo® Glasdegib

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)

Hydroxyurea

Drug name(s)

Droxia® Hydrea® Hydroxyurea

Approved for

  • Leukemia
  • Chronic Myeloid Leukemia (CML)
  • Essential Thrombocythemia
  • Polycythemia Vera

Liposomal doxorubicin

Drug name(s)

Doxil® Liposomal doxorubicin

Approved for

  • Myeloma

Nilotinib

Drug name(s)

Tasigna® Danziten Cavhanza Nilotinib

Approved for

  • Leukemia
  • Chronic Myeloid Leukemia (CML)

Pivekimab sunirine-pvzy

Drug name(s)

Pivekimab sunirine-pvzy Decnupaz™

Approved for

  • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.